Medigen Receives the 2024 “Best Cell & Gene Therapy Biopharma in APAC” Award

2024/09/11
From September 10 to 11, Medigen Biotech Corp. participated in the 8th Edition Cell and Gene Therapy, World Asia 2024 held in Singapore by IMPA. At the event's Asia Pacific Cell & Gene Therapy Excellence Awards, Medigen was honored with the “Best Cell & Gene Therapy Biopharma in APAC” award. This award, jointly voted on by industry professionals, was presented on September 10, 2024, at the Suntec Singapore Convention & Exhibition Centre. Medigen sincerely thanks global peers and experts for recognizing the company's achievements in the field of cell therapy. We remain committed to developing innovative therapeutic solutions to help treat patients and improve quality of life.

At the Suntec Singapore Convention & Exhibition Centre, Dr. James Chieh-Liang Lin of Medigen accepted the Best Cell & Gene Therapy Biopharma in APAC award from Mr. Sunil Gadekar.